Hypercoagulability states in upper-extremity deep venous thrombosis

American Journal of Hematology

Volumn 67, Issue 1, 2001, Pages 15-19

  Leebeek, F W G ^a   Stadhouders, N A M ^a   Van Stein, D ^a   Gmez Garca, E B ^a   Kappers Klunne, M C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Central venous catheter; Deep vein thrombosis; Factor V Leiden; Prothrombin; Upper extremity

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PROTEIN C;

ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; EXERCISE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCOAGULABILITY; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ARM; BLOOD COAGULATION DISORDERS; CATHETERIZATION, CENTRAL VENOUS; CONTRACEPTIVES, ORAL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0035059344     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.1070     Document Type: Article

References (17)

1. Axillary-subclavian vein thrombosis. Changing patterns of etiology, diagnostic and therapeutic modalities
2. Management of subclavian-axillary vein thrombosis: A review
3. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives
4. Frequent factor II G20210A mutation in idiopathic portal vein thrombosis
5. Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood
6. Risk factors for deep venous thrombosis of the upper extremities
7. Prevalence of lupus anticoagulant and anticardiolipin antibodies in healthy population
8. Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: A report of four patients
9. Anti-phospholipid antibody syndrome associated with peripheral T-cell lymphoma
10. Anticardiolipin antibodies: Clinical consequences of "low titers"
11. Les thromboses profondes des membres superieurs. A propos de 49 cas
12. Disseminated intravascular coagulation
13. Mutation in blood coagulation factor V associated with resistance to activated protein C
14. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
15. Hypercoagulable states in primary upper-extremity deep vein thrombosis
16. Upper-extremity deep vein thrombosis: Risk factors, diagnosis, and complications
17. Low prevalence of thrombophilic coagulation defects in patients with deep vein thrombosis of the upper limbs